• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症:高尿酸血症/痛风在心血管疾病中起致病作用的一种可能机制。

Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.

作者信息

Perez-Ruiz F, Becker M A

机构信息

a a Servicio de Reumatología, Hospital Universitario Cruces, Instituto de Investigación Biomédica BioCruces , Vizcaya , Spain.

b b Department of Medicine , The University of Chicago Pritzker School of Medicine , Chicago , Illinois , USA.

出版信息

Curr Med Res Opin. 2015;31 Suppl 2:9-14. doi: 10.1185/03007995.2015.1087980.

DOI:10.1185/03007995.2015.1087980
PMID:26414731
Abstract

Hyperuricemia and gout are independent risk factors associated with the development of hypertension, metabolic syndrome, vascular damage, and renal disease. Whether these risk factors are causally related to these important chronic co-morbidities remains uncertain, but inflammation may provide a mechanistic explanation. Hyperuricemia and gout negatively affect vascular function by exerting pro-oxidant effects and by decreasing nitric oxide bioavailability, thus inducing inflammation and endothelial dysfunction, which may promote hypertension, metabolic syndrome, and cardiovascular (CV) disease. This paper presents and discusses current understanding of the diverse influences promoting hyperuricemia and gout and the basis of acute and chronic hyperuricemia/gout-related inflammation. This review is based on a PubMed/Embase database search for articles on hyperuricemia and its impact on cardiovascular and renal function.

摘要

高尿酸血症和痛风是与高血压、代谢综合征、血管损伤及肾脏疾病发生相关的独立危险因素。这些危险因素与这些重要的慢性合并症之间是否存在因果关系尚不确定,但炎症可能提供一种机制性解释。高尿酸血症和痛风通过发挥促氧化作用以及降低一氧化氮生物利用度对血管功能产生负面影响,从而诱发炎症和内皮功能障碍,这可能会促进高血压、代谢综合征及心血管疾病的发生。本文介绍并讨论了目前对促进高尿酸血症和痛风的多种影响以及急性和慢性高尿酸血症/痛风相关炎症的基础的理解。本综述基于对PubMed/Embase数据库中关于高尿酸血症及其对心血管和肾功能影响的文章的检索。

相似文献

1
Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease.炎症:高尿酸血症/痛风在心血管疾病中起致病作用的一种可能机制。
Curr Med Res Opin. 2015;31 Suppl 2:9-14. doi: 10.1185/03007995.2015.1087980.
2
Detrimental role of hyperuricemia on the cardio-reno-vascular system.高尿酸血症对心血管系统的有害作用。
Curr Med Res Opin. 2015;31 Suppl 2:21-6. doi: 10.1185/03007995.2015.1087984.
3
Why focus on uric acid?为什么关注尿酸?
Curr Med Res Opin. 2015;31 Suppl 2:3-7. doi: 10.1185/03007995.2015.1087979.
4
Hyperuricemia, urate deposition and the association with hypertension.高尿酸血症、尿酸盐沉积及其与高血压的关联。
Curr Med Res Opin. 2015;31 Suppl 2:15-9. doi: 10.1185/03007995.2015.1087981.
5
Update on gout and hyperuricemia.痛风和高尿酸血症的最新进展。
Int J Clin Pract. 2010 Feb;64(3):371-7. doi: 10.1111/j.1742-1241.2009.02188.x. Epub 2009 Nov 10.
6
Hyperuricemia, gout, and cardiovascular disease: an update.高尿酸血症、痛风与心血管疾病:最新进展
Curr Rheumatol Rep. 2015 Mar;17(3):13. doi: 10.1007/s11926-015-0495-2.
7
Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature.高尿酸血症和/或痛风患者的心血管危险因素及合并症:文献系统综述
J Rheumatol Suppl. 2014 Sep;92:9-14. doi: 10.3899/jrheum.140457.
8
New Insight into Urate-Related Mechanism of Cardiovascular Damage.心血管损伤的尿酸相关机制新见解
Curr Pharm Des. 2014;20(39):6089-95. doi: 10.2174/1381612820666140417095730.
9
Hyperuricemia, gout, and cardiovascular disease--an important "muddle".高尿酸血症、痛风与心血管疾病——一个重要的“谜团”。
Bull NYU Hosp Jt Dis. 2009;67(3):285-90.
10
[HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].[高尿酸血症与心血管疾病和肾脏疾病的潜在风险]
Rev Med Liege. 2016 May;71(5):262-8.

引用本文的文献

1
Association between neutrophil-to-HDL cholesterol ratio and the risk of gout or hyperuricemia: evidence from NHANES 2007-2018.中性粒细胞与高密度脂蛋白胆固醇比值与痛风或高尿酸血症风险之间的关联:来自2007 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Eur J Med Res. 2025 Sep 3;30(1):839. doi: 10.1186/s40001-025-03106-0.
2
Major adverse cardiovascular events and hyperuricemia as an effect-modifying factor in kidney transplant recipients.主要不良心血管事件及高尿酸血症作为肾移植受者的效应修饰因素
World J Transplant. 2025 Sep 18;15(3):102287. doi: 10.5500/wjt.v15.i3.102287.
3
Exploring causal pathways between hypertension, lipid levels, and gout: Insights from Mendelian randomization and NHANES observations.
探索高血压、血脂水平与痛风之间的因果途径:孟德尔随机化和美国国家健康与营养检查调查(NHANES)观察结果的见解
Medicine (Baltimore). 2025 Aug 1;104(31):e43638. doi: 10.1097/MD.0000000000043638.
4
The effectiveness and safety of specific dietary supplements in modulating uric acid levels, oxidative stress, and lipid metabolism in patients: a network meta-analysis of 13 interventions.特定膳食补充剂对患者尿酸水平、氧化应激和脂质代谢的调节作用及其安全性:13种干预措施的网状Meta分析
Nutr Metab (Lond). 2025 Jul 23;22(1):80. doi: 10.1186/s12986-025-00977-2.
5
Exploration of the Interrelationship Between Serum Uric Acid, Gout, and Cardiac, Renal, and Metabolic Conditions in Middle Aged and Older People.中老年人群血清尿酸、痛风与心脏、肾脏及代谢状况之间的相互关系探究
J Am Heart Assoc. 2025 Apr;14(7):e038723. doi: 10.1161/JAHA.124.038723. Epub 2025 Mar 27.
6
Cross-sectional study on the association between serum uric acid levels and the risk of benign prostatic hyperplasia.血清尿酸水平与良性前列腺增生风险之间关联的横断面研究
BMJ Open. 2025 Mar 18;15(3):e092844. doi: 10.1136/bmjopen-2024-092844.
7
A retrospective study of the association between serum uric acid and risk of coronary heart disease complicated with different types of chronic heart failure.一项关于血清尿酸与冠心病合并不同类型慢性心力衰竭风险之间关联的回顾性研究。
Eur J Med Res. 2025 Mar 1;30(1):146. doi: 10.1186/s40001-025-02403-y.
8
[Colchicine-Phoenix from the ashes].[秋水仙碱——浴火重生]
Wien Klin Wochenschr. 2025 Feb;137(Suppl 1):1-33. doi: 10.1007/s00508-024-02490-7. Epub 2025 Feb 6.
9
Hyperuricemia and Gout are Associated with the Risk of Atrial Fibrillation: An Updated Meta-Analysis.高尿酸血症和痛风与心房颤动风险相关:一项更新的荟萃分析。
Rev Cardiovasc Med. 2022 May 16;23(5):178. doi: 10.31083/j.rcm2305178. eCollection 2022 May.
10
Randomised, double-blind, placebo-controlled study evaluating the effect of allopurinol on the risk of cardiovascular events in patients with high and very high cardiovascular risk, including the presence of long-COVID-19 syndrome: the ALL-VASCOR study protocol.一项随机、双盲、安慰剂对照研究,评估别嘌醇对高心血管风险和极高心血管风险患者(包括长新冠综合征)心血管事件风险的影响:ALL-VASCOR 研究方案。
BMJ Open. 2024 Jul 24;14(7):e075741. doi: 10.1136/bmjopen-2023-075741.